Le Lézard
Classified in: Health
Subjects: WOM, CFG, MAT

Statement by the Prime Minister on International Safe Abortion Day


OTTAWA, ON, Sept. 28, 2022 /CNW/ - The Prime Minister, Justin Trudeau, today issued the following statement on International Safe Abortion Day:

"Today, on International Safe Abortion Day, we reaffirm our unwavering commitment to upholding a woman's fundamental right to choose. No one should ever be forced to carry an unwanted pregnancy, and the Government of Canada is unequivocal in that pursuit.

"Here in Canada, we have had access to safe and legal abortions for almost 35 years thanks to decades of hard-fought activism. Abortion is covered under our universal health care system. But there is still more work to be done to improve accessibility, particularly in rural and remote communities. In May, the Government of Canada announced funding to support civil society organizations, such as Action Canada for Sexual Health and Rights and the National Abortion Federation Canada, to strengthen access to safe and inclusive sexual and reproductive health services, including by offering financial assistance to cover travel costs for those seeking an abortion and training for health care providers offering abortion services.

"Abortions are an essential health service which, when performed following medical guidelines, are safe. Unfortunately, nearly half of all abortions performed worldwide are unsafe and these unsafe abortions are a leading cause of maternal deaths. Tragic and preventable deaths will continue for as long as women are denied the right to make choices for their own bodies. That's why we're helping to advance sexual and reproductive health and rights in developing countries, with funding to improve access to safe abortions, post-abortion care, and family planning.

"Today, we reflect on the progress we have made and the work that still needs to be done to ensure everyone has access to a safe abortion, including standing up to those who want to take us backwards. To those at home and around the world continuing to fight for their safety and their bodily autonomy: know that we will always stand up for your right to choose."

This document is also available at https://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...



News published on and distributed by: